Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril morning vs evening in type 2 diabetes and hypertension
NCT03393715Phase 4Completed
- Sponsor
- Yaoundé Central Hospital
- Start
- Feb 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of perindopril in hypertension (HTN), sponsored by Yaoundé Central Hospital. Started Feb 2016; status: completed.
02
Drugs
perindopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03393715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03393715.